BIOCERES CROP SOLUTIONS CORP (BIOX) Stock Analyst Ratings
NASDAQ:BIOX - Nasdaq - KYG1117K1141 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to BIOX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.77. This target is 99.85% above the current price.
BIOX was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about BIOX.
In the previous month the buy percentage consensus was at a similar level.
BIOX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-21 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-09-11 | Roth MKM | Maintains | Buy -> Buy |
| 2024-09-11 | Lake Street | Maintains | Buy -> Buy |
| 2024-09-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-09-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-07-02 | Roth MKM | Reiterate | Buy |
| 2024-02-09 | Roth MKM | Maintains | Buy -> Buy |
| 2023-11-01 | Roth MKM | Maintains | Buy -> Buy |
| 2023-09-12 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-09-12 | Lake Street | Maintains | Buy -> Buy |
| 2023-08-16 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-04-06 | Oppenheimer | Initiate | Outperform |
| 2022-09-30 | Canaccord Genuity | Initiate | Buy |
| 2021-10-08 | Roth Capital | Initiate | Buy |
| 2021-03-15 | Lake Street | Initiate | Buy |